“Safety and Immunogenicity of a PHH-1V Booster Dose After Different Prime Vaccination Schemes Against Covid-19: Phase III Clinical Trial Final Results Up To One Year”. 2024. Archives of Clinical and Biomedical Research 8 (4): 326-42. https://fortunejournals.org/ojs/index.php/acbr/article/view/15082.